Investment firm HC Wainwright initiates coverage on Metagenomi (NASDAQ:MGX) with a buy rating and $10.00 price target.
HC Wainwright begins coverage on Metagenomi (NASDAQ:MGX) with a buy rating and $10.00 price target. Q1 2024 EPS forecast is ($1.20) EPS, with additional estimates for Q2-Q4 2024 and FY 2024-2025. Other research firms such as Jefferies Financial Group and Wells Fargo & Company have also initiated coverage with buy ratings and price targets of $23.00 and $25.00 respectively.
May 11, 2024
3 Articles